COPD

With legalization of cannabis across much of the United States and all of Canada, Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, has concerns about the effect of wider cannabis usage on chronic obstructive pulmonary disease (COPD) in future decades.

Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, discusses future possibilities for the prevention of chronic obstructive pulmonary disease (COPD) using new biomarker discoveries and genomic technology advancements.

Interest in the use of digital inhalers is growing, as they may provide real-world evidence about how patients monitor and treat their chronic obstructive pulmonary disease (COPD) and asthma at home, but additional questions need to be answered, according to a recent review.

High-flow nasal therapy overcomes some of the barriers associated with noninvasive ventilation, making the novel support beneficial for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD).

The role that eosinophilic chronic obstructive pulmonary disease (COPD) plays in the pathogenesis of COPD is not well understood, given the lack of evidence about the subject.

The prevalence of chronic obstructive pulmonary disease (COPD) underdiagnosis, false diagnosis, and treatment in the primary care setting is high and often inconsistent with Global Initiative for the Chronic Obstructive Lung Disease (GOLD) guidelines.

Investigators anticipate the results will help physicians tailor treatment methods for patients with chronic obstructive pulmonary disease (COPD) and help to better understand the demographic and clinical implications on peak inspiratory flow.

Blood eosinophil count is a promising biomarker and example of the pathway toward precision medicine in chronic obstructive pulmonary disease (COPD), said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.

Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting. Another poster validated the use of the COPD Treatment Ratio as a measure of exacerbation risk.

Focusing therapeutic trials on 1 subtype of chronic obstructive pulmonary disease (COPD) can help lead to smaller, targeted studies, which in can help advance precision medicine, said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.

Older adults with coexisting asthma and chronic obstructive pulmonary disease (COPD), known as asthma-COPD overlap, who take fixed-dose combinations of inhaled corticosteroids and long-acting β agonists may be less likely to have persistent low adherence to initial maintenance therapy.

The influenza vaccination may be associated with lower risks of ventricular arrhythmia in patients with chronic obstructive pulmonary disease (COPD).

Community participation by individuals with chronic obstructive pulmonary disease (COPD) resulted in better lung function, improved exercise capacity, and less breathlessness, according to a recent study.

Two abstracts presented at CHEST 2021 outlined risk factors for exacerbations of chronic obstructive pulmonary disease (COPD) among veterans.

A recent study found that nurses who worked in operating rooms for 15 or more years are 46% to 69% more likely to develop chronic obstructive pulmonary disease (COPD) than nurses who had never worked in an operating room.

A report suggests that people with chronic obstructive pulmonary disease (COPD) and asthma have a protein in their lungs that leaks a small molecule into their bloodstream that restricts their breathing instead of relaxing their airways.

Researchers in Spain investigated whether implementation of a pulmonary embolism diagnostic strategy improved outcomes among patients with chronic obstructive pulmonary disease (COPD).

The study found that a combination of the Chinese symptom-based questionnaire and microspirometry could provide the most efficient and cost-effective way of identifying patients who need treatment for COPD.

The study aimed to identify the usefulness of telemonitoring to detect and manage acute exacerbation of COPD (AECOPD).

A review gives an overview of potential biomarkers in chronic obstructive pulmonary disease.

Results of a longitudinal study outline the relationship between depression and patients reported outcomes among those with chronic obstructive pulmonary disease (COPD).

On top of a general rise in chronic obstructive pulmonary disease (COPD) rates, the study found data suggesting increases not tied to a past history of smoking in several occupations.

This study explores the association between receiving noninvasive ventilation at home and mortality, hospitalizations, and emergency department visits in patients with chronic obstructive pulmonary disease (COPD) with chronic respiratory failure (CRF).

Symptoms of late-stage chronic obstructive pulmonary disease (COPD) were more controlled when patients received palliative care, according to the Swedish study.

The study, conducted in Spain, sought to determine the factors that created a higher risk of death from acute exacerbations of chronic obstructive pulmonary disease (COPD) in primary care.

This study is one of only a handful to explore barriers to pulmonary rehabilitation in Iran for patients with chronic obstructive pulmonary disease (COPD).

Worsening chronic obstructive pulmonary disease (COPD) symptoms are often underreported by patients who cannot recognize these changes as sign of decline, but they can be objectively measured through remote patient monitoring (RPM).

A new study offers insight into ways to decrease the burden on caregivers for patients with chronic obstructive pulmonary disease (COPD) in China and around the world.

Patients with chronic obstructive pulmonary disease (COPD) who experienced handgrip strength (HGS) weakness may be more susceptible to exacerbation, a new study shows.

Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk score for COPD exacerbations.